Quality assurance guarantees constant innovation

Our non-invasive genetic screening service Prendia (VeriSeq NIPT Solution v2 system, Illumina), is CE-IVD marked. The test is performed entirely in our laboratory, in Switzerland, under the ISO15189 accreditation standard..

For complete double-checking of the Prendia VeriSeq results, Genesupport has developed a three-pronged scheme.

First i) a birth register allowing to verify results without evidence of anomalies; second ii) a register allowing the tracking of findings assumed to be limited to the placenta and not affecting the fetus by analysis of the placenta (PDF biopsy of placenta) and third iii) a register for the complete documentation of pathological amniotic fluid test results affecting directly the fetus.

Thank you for your cooperation!

Prendia - Quality assurance